Veraxa Biotech AG recorded a single insider purchase of 6,024 shares by Warren Hosseinion on September 10, 2026, totaling $10,060.08. This acquisition occurred amid a 35.8% decline in stock value over the past ninety days, with the equity currently trading near its fifty-two-week low.